Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Anaesthesia, Pain and Intensive Care. 2016; 20 (2): 150-153
in English | IMEMR | ID: emr-182254

ABSTRACT

Objectives: Propofol is one of the mainly used intravenous anaesthetic used around the globe.However, it is commonly associated with intravascular pain at the time of administration. In this study, we wanted to determine the effectiveness of Tramadol in comparison to Lignocaine in reducing Propofol induced pain


Study Design: Randomized clinical trial


Study Setting: It was performed in Main Operation Theatre, AK CMH Rawalakot; over a period of seven Months from 27-09-2013 to 27-04-2014


Subjects and Methods: 100 patients, having ASA I and ASA II who had presented for elective surgery, were included in the study. Patients with psychiatric disorder or hypersensitivity to lignocaine, propofol or tramadol were excluded. They were divided into two groups of 50 each. Group A received 50 mg intravenous Tramadol, followed by 25 % of dose calculated for Propofol [2 mg/kg]. Drugs were injected into most prominent vein of hand, using 20 G cannula, at rate of 1 ml/sec. Group B received 2 ml of 2 % lignocaine, followed by Propofol in same manner. IBM SPSS version 20 was used for statistical analysis. Independent sample T-test was used for find out p value for age. Chi square was used to find out p value for gender and pain. Pain was assessed by anesthetist as per patient's facial response or complaint of pain


Results: Mean age was 31.94 +/- 17.59 and 29.86 +/- 13.58 in group- A and B respectively [P value=0.07]. Group A comprised of 33 female and 17 males, whereas Group B comprised of 30 females and 20 males [P value =0.534]. Pain was present in 7 [14%] patients in group A as compared to 11 [22%] patients in group B [P value=0.298]. Statistically the difference in regards to gender or pain was insignificant


Conclusion: The study concludes that there is no significant difference between pretreatment with tramadol or lignocaine, in relieving pain caused by propofol?

2.
Anaesthesia, Pain and Intensive Care. 2016; 20 (1): 17-20
in English | IMEMR | ID: emr-182282

ABSTRACT

Objective: Hypotension is the commonest side effect associated with spinal anesthesia. Multiple modalities have been tested to find adequate preventive measure. Main objective of this study is to find out the effectiveness of prophylactic administration of inj. ondansetron for prevention of spinal anesthesia induced hypotension in elderly patients


Study design: Double blind, randomized controlled trial


Place and duration of study: This study was conducted in our anesthesiology department from 01 July 2014 to 31 December 2014


Methodology: 100 patients were selected for the study using non-probability sampling technique, and divided into two groups of 50 each using random numbers table. Each patient was preloaded with ringer's lactate solution in a dose of 10 ml/kg Patients of Group A received 8 mg of ondansetron IV five minutes prior to administration of spinal anesthesia; whereas patients of Group B were injected normal saline IV. Data were collected and analyzed using IBM SPSS version 20. Chi square test was used to compare hypotension between two groups. A p-value < 0.05 was taken as significant


Results: Mean age of Group A was 64.16 +/- 8.47 years, whereas that of Group B was 62.58 +/- 8.99 [p value= 0.39]. Mean weight of Group A was 72.64 + 5.82 kg, whereas that of Group B was 70.66 + 5.96 kg [p = value p- 0.295]. Hypotension was present in 23 [46%] patients in Group A, where as it was present in 34 [68%] patients in Group B [p value= 0.026]. Bradycardia was recorded in 3[06%] vs. 11 [22%] patients in Group A and B respectively [p=0.021]


Conclusion: We conclude that intravenous administration of 8 mg of ondansetron, 5 minutes prior to subarachnoid block, is effective in decreasing frequency of hypotension and bradycardia in elderly patients

3.
Anaesthesia, Pain and Intensive Care. 2016; 20 (1): 77-79
in English | IMEMR | ID: emr-182296

ABSTRACT

Snake bite is quite common in most of the countries of the world, especially tropics and subtropical areas. The snake venom is usually one of the two types; neurotoxins and hemotoxins or hemolysins. The management of snake bite consists of supportive treatment and anti-snake venom serum. The patients suffering from respiratory problems due to muscular paralysis will require mechanical ventilatory support. We present a case of a victim of black mamba bite, which is one of the most dreaded snakes in Africa. His recovery was slow and marred with coagulation profile derangement. Finally we started neostigmine and atropine and witnessed a dramatic improvement in his muscle power. He rapidly improved and was discharged with complete recovery

SELECTION OF CITATIONS
SEARCH DETAIL